Full name

A Randomized, Double-blind, Parallel Group, Multi-center Study to Evaluate the Long-term Safety of Salbutamol Rescue Medication When Administered Via Metered Dose Inhalers Containing the Propellant HFA-152a or Reference HFA-134a

NCT Number
NCT06261957
Geography
US
Non-US
Locations

Argentina, Australia, Canada, France, Greece, Italy, Panama, Philippines, Poland, Spain, Thailand, United Kingdom, United States

Primary Endpoints

Number of participants with Adverse Events (AEs). Up to 3 months

Order
5
Disease
Asthma
Menu title
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
Version
NMA 2025
Phase
3
Status
Recruiting